Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies

Neurology

Volumn 85, Issue 19, 2015, Pages 1680-1686

  Labbé, Catherine ^a   Ogaki, Kotaro ^a   Lorenzo Betancor, Oswaldo ^a   Soto Ortolaza, Alexandra I ^a   Walton, Ronald L ^a   Rayaprolu, Sruti ^a   Fujioka, Shinsuke ^b   Murray, Melissa E ^a   Heckman, Michael G ^b   Puschmann, Andreas ^e,f   McCarthy, Allan ^c,d   Lynch, Timothy ^c,d   Siuda, Joanna ^g   Opala, Grzegorz ^g   Rudzinska, Monika ^h   Krygowska Wajs, Anna ^h   Barcikowska, Maria ⁱ   Czyzewski, Krzysztof ^j   Sanotsky, Yanosh ^k   Rektorová, Irena ^l   McLean, Pamela J ^b   Rademakers, Rosa ^a   Ertekin Taner, Nilüfer ^a,b   Hassan, Anhar ^m   Ahlskog, J Eric ^m   Boeve, Bradley F ^m   Petersen, Ronald C ^m   Maraganore, Demetrius M ⁿ   Adler, Charles H ^o   Ferman, Tanis J ^b   Parisi, Joseph E ^m   Graff Radford, Neill R ^b   Uitti, Ryan J ^b   Wszolek, Zbigniew K ^b   Dickson, Dennis W ^a   Ross, Owen A ^a,b   more..

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e LUND UNIVERSITY   (Sweden)

^f LUND UNIVERSITY HOSPITAL   (Sweden)

^g MEDICAL UNIVERSITY OF SILESIA   (Poland)

^h JAGIELLONIAN UNIVERSITY   (Poland)

ⁱ MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^j Central Hospital   (Poland)

^k Lviv Regional Clinical Hospital   (Ukraine)

^l MASARYK UNIVERSITY   (Czech Republic)

^m MAYO CLINIC   (United States)

ⁿ NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^o MAYO CLINIC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN; ALPHA SYNUCLEIN; MAPT PROTEIN, HUMAN;

ADULT; AGED; ALPHA SYNUCLEINOPATHIES; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIFFUSE LEWY BODY DISEASE; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SHY DRAGER SYNDROME; ADOLESCENT; EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; LEWY BODY DISEASE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; TAU PROTEINS; YOUNG ADULT;

EID: 84946916693     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001946     Document Type: Article

References (24)

1. McCann H, Stevens CH, Cartwright H, Halliday GM. Alpha-synucleinopathy phenotypes. Parkinsonism Relat Disord 2014;20(suppl 1):S62-S67.
2. Jenner P, Morris HR, Robbins TW, et al. Parkinson's disease: the debate on the clinical phenomenology, aetiology, pathology and pathogenesis. J Parkinson Dis 2013;3:1-11.
3. Nalls MA, Pankratz N, Lill CM, et al. Large-scale metaanalysis of genome-wide association data identifies six new risk loci for Parkinson's disease. Nat Genet 2014;46:989-993.
4. Lill CM, Roehr JT, McQueen MB, et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: the PDGene database. Plos Genet 2012;8:e1002548.
5. Sharma M, Ioannidis JP, Aasly JO, et al. Large-scale replication and heterogeneity in Parkinson disease genetic loci. Neurology 2012;79:659-667.
6. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705.
7. Pittman AM, Fung HC, de Silva R. Untangling the tau gene association with neurodegenerative disorders. Hum Mol Genet 2006;15(Spec 2):R188-R195.
8. Kovacs GG, Wohrer A, Strobel T, Botond G, Attems J, Budka H. Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. Clin Neuropathol 2011;30:3-10.
9. Coppola G, Chinnathambi S, Lee JJ, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Hum Mol Genet 2012;21:3500-3512.
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
11. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65:1863-1872.
12. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008;71:670-676.
13. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 1991;82:239-259.
14. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47:1113-1124.
15. Labbe C, Soto-Ortolaza AI, Rayaprolu S, et al. Investigating the role of FUS exonic variants in essential tremor. Parkinsonism Relat Disord 2013;19:755-757.
16. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007;81: 559-575.
17. Skipper L, Wilkes K, Toft M, et al. Linkage disequilibrium and association of MAPT H1 in Parkinson disease. Am J Hum Genet 2004;75:669-677.
18. Bras J, Guerreiro R, Darwent L, et al. Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies. Hum Mol Genet 2014;23:6139-6146.
19. Vilarino-Guell C, Soto-Ortolaza AI, Rajput A, et al. MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy. Neurology 2011; 76:670-672.
20. Kara E, Ling H, Pittman AM, et al. The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobiol Aging 2012;33:2231.e7-2231.e14.
21. Moussaud S, Jones DR, Moussaud-Lamodiere EL, Delenclos M, Ross OA, McLean PJ. Alpha-synuclein and tau: teammates in neurodegeneration? Mol Neurodegen 2014;9:43.
22. Muntane G, Dalfo E, Martinez A, Ferrer I. Phosphorylation of tau and alpha-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer's disease, and in Parkinson's disease and related alpha-synucleinopathies. Neuroscience 2008;152:913-923.
23. Duda JE, Giasson BI, Mabon ME, et al. Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred. Acta Neuropathol 2002;104:7-11.
24. Giasson BI, Forman MS, Higuchi M, et al. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science 2003;300:636-640.